PNEUMOCYSTIS JIROVECII INFECTION
Clinical trials for PNEUMOCYSTIS JIROVECII INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECII INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECII INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could shorter steroid courses be safer for severe pneumonia patients?
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with a severe type of pneumonia (PCP) who have weak immune systems. Patients who get better quickly are split into two groups: one stops steroids after 10 days, the other continues for 21 days. The goal is to see if …
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
Which PCP treatment works best when standard antibiotics fail?
Disease control Not yet recruitingThis study looks at people with a serious lung infection called Pneumocystis pneumonia (PCP) who cannot take the usual antibiotic due to allergies, side effects, or poor response. Researchers will compare different alternative treatments to see which one works best and is safest.…
Matched conditions: PNEUMOCYSTIS JIROVECII INFECTION
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 14, 2026 12:05 UTC